A DNA methylation-based liquid biopsy for triple-negative breast cancer.

Cristall, Katrina; Bidard, Francois-Clement; Pierga, Jean-Yves; Rauh, Michael J; Popova, Tatiana; Sebbag, Clara; Lantz, Olivier; Stern, Marc-Henri; Mueller, Christopher R

Cristall, Katrina; Bidard, Francois-Clement; Pierga, Jean-Yves; Rauh, Michael J; Popova, Tatiana; Sebbag, Clara; Lantz, Olivier; Stern, Marc-Henri; Mueller, Christopher R.

Affiliation

Cristall K; Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada.
Bidard FC; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Pierga JY; Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, Paris, France.
Rauh MJ; Department of Medical Oncology, Institut Curie, Paris, France.
Popova T; Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, Paris, France.
Sebbag C; Department of Medical Oncology, Institut Curie, Paris, France.
Lantz O; Université Paris Descartes, Paris, France.
Stern MH; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Mueller CR; INSERM U830 Cancer, Heterogeneity, Instability and Plasticity (CHIP), Institut Curie, Paris, France.

NPJ Precis Oncol ; 5(1): 53, 2021 Jun 16.

Article de En | MEDLINE | ID: mdl-34135468

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: NPJ Precis Oncol Année: 2021 Type de document: Article Pays d'affiliation: Canada

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google